Delivery Order SPE2DB20D9135-SPE2DB23FZW86

Award Date 8/9/23
Potential Completion Date 8/30/23
Potential Value $2.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The award, valued at $11,605.50, is for the supply of Xolair 75 mg/0.5 ml syringes to support the recurring medical supply needs of military health facilities worldwide. The delivery order was issued under DMS Pharmaceutical Group's existing indefinite delivery contract (IDC) with the DLA,...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $11,605.50 contract is for the supply of Xolair 75 mg/0.5 ml syringes to support the recurring medical supply needs of military health facilities. The award is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $2,707.95 contract is for the supply of Xolair 75 mg/0.5 ml syringes to support the recurring medical supply needs of military health facilities. The delivery order was issued under a larger $499,999,999 single-award indefinite delivery contract (IDC) with the DLA, which allows the...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $2,321.10, is for the delivery of Xolair 75 mg/0.5 ml syringes to support the medical supply needs of military healthcare facilities. This contract award is not associated with any set-aside designation. DMS Pharmaceutical Group Inc. holds a larger Indefinite...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The award, valued at $2,321.10, is for the delivery of Xolair 75 mg/0.5 ml syringes. The contract is a firm fixed-price delivery order issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with the DLA, valued at $499,999,999 and valid through November 2026. This IDC allows the...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $13,926.60, is for the delivery of Xolair 75 mg/0.5 ml syringes to support the medical supply needs of military health facilities. The award is not associated with a set-aside designation. DMS Pharmaceutical Group holds a significant single-award Indefinite Delivery...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $3,868.50, is for the supply of Xolair 75 mg/0.5 ml syringe 0.5 ml to support the recurring medical supply needs of military health facilities. The award is part of a larger indefinite delivery contract (IDC) with DLA under the SPE2DB program, valued at up to...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,934.25 contract is for the supply of Xolair 75 mg/0.5 ml syringes to support the recurring medical supply needs of military health facilities worldwide. DMS Pharmaceutical Group holds a significant single-award indefinite delivery contract (IDC) with the DLA under the...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $11,162.88, is for the delivery of Xolair 300 mg/2 ml syringes to support the medical supply needs of military healthcare facilities. The award is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $2,321.10 contract is to provide a pharmaceutical product, specifically XOLAIR 150 MG/ML SYRINGEML, to support the recurring medical supply needs of military health facilities worldwide. The award is issued under DMS Pharmaceutical Group's existing indefinite delivery contract (IDC) with...
  • SPE2DB20D9135
    Indefinite Delivery Contract
  • SPE2DB20D9135-SPE2DB23FZW86
    Delivery Order

This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $2,321.10 award is for the delivery of Xolair 75 mg/0.5 ml syringes to support the recurring medical supply needs of military health facilities.

The award was made under DMS Pharmaceutical Group's $499,999,999 indefinite delivery contract (IDC) with the DLA, which allows the agency to issue delivery orders for a comprehensive range of pharmaceutical items. This single-award IDC, which runs through December 31, 2025, solidifies DMS Pharmaceutical Group's position as a crucial supplier in the federal pharmaceutical supply chain, providing both routine and critical medications to support the diverse medical needs of military personnel and their dependents across various Department of Defense healthcare facilities. The contract has no set-aside designation.

Generated 1/9/25, 9:36 AM